Evaluation of Bacterial and Fungal Contamination During Propofol Continuous Infusion

• Status: Unknown status
• Trial end date: 2009-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to verify the existence of bacterial and/or fungal contamination during different technics of propofol with or without EDTA continuous infusion in patients undergoing general anesthesia.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Sao Paulo
• Collaborator: AstraZeneca
• Treatments: Edetic Acid; Pentetic Acid; Propofol

Criteria

Inclusion Criteria:

• Age eighteen years old or more

• ASA Physiological Status P1 ou P2

• Patients undergoing clean procedure under general anesthesia.

Exclusion Criteria:

• Patients under eighteen years old

• ASA Physiological Status P3, P4 or P5

• Current infectious process